2m 2m 2m 2m 2m 2m - S&P 600$1,709.07
2m
ROIVANT SCIENCES (ROIV)
NASDAQ
$39.69+$0.16 (+0.39%)
Price as of Nov 13, 2026 7:55 PM EST- $28.5BMarket Cap
- 94.83%1-Year Change
- BiotechnologyIndustry
ROIVANT SCIENCES (ROIV)
$39.69+$0.16 (+0.39%)
ROIV | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $39.53 | ||
Change | -$0.46 (-1.15%) | ||
Open | $39.82 | ||
High | $39.88 | ||
Low | $39.16 | ||
Previous Close | $39.99 | ||
Volume | 7,194,663 | ||
30-Day Average Volume | 8,091,430 | ||
1-Week Change | 1.67% | ||
1-Month Change | 18.53% | ||
1-Year Change | 94.83% | ||
3-Year Change | 336.80% | ||
5-Year Change | 370.60% | ||
Fundamentals | |||
Shares Outstanding | 713.5M | ||
Total Assets | $5.0B | ||
Market Cap | $28.5B | ||
Enterprise Value | $26.9B | ||
Period: QTR TTM FY | |||
Revenue | $31.0M | ||
Net Income | -$191.6M | ||
Free Cash Flow | $594.2M | ||
EBIT | -$205.0M | ||
EBITDA | -$204.4M | ||
Net Working Capital | $4.1B | ||
EPS | -$0.27 | ||
Enterprise Value/EBITDA | -132 | ||
Enterprise Value/Revenue | 868 | ||
P/B | 7 | ||
P/E | -146 | ||
PEG | 38 | ||
Price/Free Cash Flow | 47 | ||
Price/Operating Cash Flow | 47 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue